文献速递肝病

酒精相关肝病组织学分级与分期系统的建立及预后价值

Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease.
PubMed 文献 · J Hepatol · 2021-06-11

SALVE组织病理学组建立并验证了覆盖酒精相关肝病(ALD)全临床与组织学谱系的分级分期系统,并在445例跨国队列中评估其预后效用。分级参数观察者间κ值均>0.6;失代偿期短期预后与活动度分级、hASH及胆汁淤积相关,代偿期无失代偿生存与hASH及严重纤维化/肝硬化相关;严重肝硬化是全队列长期生存的独立组织学预测因子。

要点

  • SALVE分级分期系统可重复性好,各参数观察者间κ值均>0.6。
  • 失代偿ALD短期预后与活动度分级、hASH、胆汁淤积相关。
  • 代偿ALD无失代偿生存与hASH及严重纤维化/肝硬化相关。

核心结论

  • SALVE分级分期系统是评估ALD疾病活动度和纤维化的可重复且具有预后相关性的组织学方法。

研究设计与样本

  • SALVE组织病理学组开发并验证了ALD分级分期系统,并在4个欧洲中心445例患者的跨国队列中评估其预后效用。

主要发现

  • 全研究队列中,长期结局与活动度分级、胆汁淤积及伴极宽间隔的肝硬化(严重肝硬化)相关(所有参数p<0.001)。
  • 失代偿ALD中,不良短期结局与活动度分级、hASH和胆汁淤积相关(p分别为0.038、0.012和0.001)。
  • 代偿ALD中,hASH和严重纤维化/肝硬化与无失代偿生存相关(p分别为0.011和0.001)。
  • 多变量分析中,严重肝硬化是全研究队列长期生存的独立组织学预测因子。
  • 严重肝硬化和hASH被确定为失代偿ALD短期生存的独立预测因子,也是代偿ALD无失代偿生存的独立预测因子。

关键数值与推荐

  • SALVE分级通过脂肪变、活动度(肝细胞损伤和小叶中性粒细胞)及胆汁淤积的半定量评分描述。
  • ALD的组织学脂肪性肝炎(hASH)诊断基于肝细胞气球样变和小叶中性粒细胞的存在。
  • 纤维化分期改编自非酒精性脂肪性肝病的临床研究网络分期系统和Laennec分期系统,反映ALD纤维化的模式和范围。
  • SALVE纤维化分期(SFS)共7期,从无纤维化到严重肝硬化。
  • 各分级和分期参数的观察者间κ值均>0.6。

临床怎么用

  • 对于接受肝活检的ALD患者,可采用SALVE系统评估疾病活动度和纤维化程度以辅助预后判断。
  • 严重肝硬化可作为全队列长期生存的独立组织学预测指标。
  • 在失代偿ALD中,活动度分级、hASH和胆汁淤积可提示短期不良结局风险。
  • 在代偿ALD中,hASH和严重纤维化/肝硬化可提示无失代偿生存风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The SALVE Histopathology Group (SHG) developed and validated a grading and staging system for the clinical and full histological spectrum of alcohol-related liver disease (ALD) and evaluated its prognostic utility in a multinational cohort of 445 patients. METHODS: SALVE grade was described by semiquantitative scores for steatosis, activity (hepatocellular injury and lobular neutrophils) and cholestasis. The histological diagnosis of steatohepatitis due to ALD (histological ASH, hASH) was based on the presence of hepatocellular ballooning and lobular neutrophils. Fibrosis staging was adapted from the Clinical Research Network staging system for non-alcoholic fatty liver disease and the Laennec staging system and reflects the pattern and extent of ALD fibrosis. There are 7 SALVE fibrosis stages (SFS) ranging from no fibrosis to severe cirrhosis. RESULTS: Interobserver κ-value for each grading and staging parameter was >0.6. In the whole study cohort, long-term outcome was associated with activity grade and cholestasis, as well as cirrhosis with very broad septa (severe cirrhosis) (p <0.001 for all parameters). In decompensated ALD, adverse short-term outcome was associated with activity grade, hASH and cholestasis (p = 0.038, 0.012 and 0.001, respectively), whereas in compensated ALD, hASH and severe fibrosis/cirrhosis were associated with decompensation-free survival (p = 0.011 and 0.001, respectively). On multivariable analysis, severe cirrhosis emerged as an independent histological predictor of long-term survival in the whole study cohort. Severe cirrhosis and hASH were identified as independent predictors of short-term survival in decompensated ALD, and also as independent predictors of decompensation-free survival in compensated ALD. CONCLUSION: The SALVE grading and staging system is a reproducible and prognostically relevant method for the histological assessment of disease activity and fibrosis in ALD. LAY SUMMARY: Patients with alcohol-related liver disease (ALD) may undergo liver biopsy to assess disease severity. We developed a system to classify ALD under the microscope by grading ALD activity and staging the extent of liver scarring. We validated the prognostic performance of this system in 445 patients from 4 European centers.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Lackner C, Stauber RE, Davies S, et al. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease. J Hepatol. 2021. PMID: 34126105. doi:10.1016/j.jhep.2021.05.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。